Design Therapeutics Inc Financial Flexibility Index
Design Therapeutics Inc financial flexibility index. Design Therapeutics Inc (DSGN) has a Financial Flexibility Index of -0.93x as of September 2025. Free cash flow of $-11.16 Million (operating CF $-11.16 Million minus capex $0.00) represents -1% of total liabilities ($12.05 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Design Therapeutics Inc (2019–2024)
Financial flexibility index of Design Therapeutics Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Design Therapeutics Inc across 6 annual periods. Explore cash flow to debt ratio of Design Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Design Therapeutics Inc Financial Flexibility Index by Year (2019–2024)
Design Therapeutics Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Design Therapeutics Inc. For the full cash flow conversion analysis, see DSGN cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.28x | $-42.77 Million | $-43.10 Million | $10.00 Million | ▲ +12.3% |
| 2023 | -4.88x | $-58.30 Million | $-58.56 Million | $11.96 Million | ▼ -33.8% |
| 2022 | -3.64x | $-50.40 Million | $-51.32 Million | $13.83 Million | ▼ -10.3% |
| 2021 | -3.30x | $-27.84 Million | $-29.38 Million | $8.43 Million | ▼ -1738.8% |
| 2020 | -0.18x | $-8.59 Million | $-8.67 Million | $47.83 Million | ▼ -964.2% |
| 2019 | -0.02x | $-63.00K | $-139.00K | $3.73 Million | — |